EUVIMEDEUVIMED entdecken
Crossref

Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation

Zhuo Wang, Zachary McCalla, Li Lin, Dominic Tornichio, Yaw Agyemang, John A Bastulli, Xiaochun Susan Zhang, Hao-Jie Zhu, Xinwen Wang

Drug Metabolism and Disposition · 2025-01 · 53 (1) · 100023

DOI: 10.1124/dmd.124.001916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-01. Verfasst von Zhuo Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio. Hauptthemen laut MEDLINE: Carboxylic Ester Hydrolases, Polymorphism, Genetic, Benzodiazepines, Carboxylesterase. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carboxylic Ester HydrolasesPolymorphism, GeneticBenzodiazepinesCarboxylesteraseHypnotics and SedativesHumansDrug InteractionsHydrolysisLiverMicrosomes, LiverMale

Stichwörter der Autor:innen

Carboxylesterase 1 (CES1)Drug metabolismDrug-drug Interaction (DDI)PharmacogenomicsRemimazolam

Substanzen

Carboxylic Ester HydrolasesCES1 protein, humanremimazolamBenzodiazepinesCarboxylesteraseHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio.
  • Department of Surgery, Northeast Ohio Medical University, Rootstown, Ohio.
  • Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan.
  • Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio. Electronic address: xwang2@neomed.edu.

Zitieren

APA

Wang, Z., McCalla, Z., Lin, L., Tornichio, D., Agyemang, Y., Bastulli, J. A., Zhang, X. S., Zhu, H. J., & Wang, X. (2025). Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation. Drug Metabolism and Disposition, 53(1), 100023. https://doi.org/10.1124/dmd.124.001916

Vancouver

Wang Z, McCalla Z, Lin L, Tornichio D, Agyemang Y, Bastulli JA, et al. Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation. Drug Metabolism and Disposition. 2025;53(1):100023. doi:10.1124/dmd.124.001916

BibTeX
@article{Wang2025,
  author = {Wang, Zhuo and McCalla, Zachary and Lin, Li and Tornichio, Dominic and Agyemang, Yaw and Bastulli, John A and Zhang, Xiaochun Susan and Zhu, Hao-Jie and Wang, Xinwen},
  title = {Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  volume = {53},
  number = {1},
  pages = {100023},
  doi = {10.1124/dmd.124.001916}
}
Kostenlos starten →